Search tips
Search criteria 


Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. 1988 October; 47(10): 849–854.
PMCID: PMC1003615

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.


Because thrombocytopenia occurs frequently in patients with anticardiolipin (aCL) antibodies and thrombosis, some investigators have proposed that aCL antibodies may play a direct part in thrombosis by binding and activating platelets. To test this proposal experiments were performed to determine whether aCL antibodies can bind platelets. Preincubation of aCL positive sera with freeze-thawed platelets caused significant inhibition of aCL activity in four serum samples tested. Antibodies with cardiolipin binding activity were subsequently eluted from these platelets. Total phospholipids extracted from platelets inhibited aCL activity, and the specific phospholipids bound were shown to be phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol. It is concluded that aCL antibodies can bind phospholipids in platelet membranes but pertubation of the membrane must first occur.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (830K), or click on a page image below to browse page by page.

Images in this article

Click on the image to see a larger version.

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group